Makoto Kajizono

IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1–42 by Rat Primary Type 2 Microglia

Eisuke Shimizu, Kohichi Kawahara, Makoto Kajizono et al. · The Journal of Immunology · 2008 · 146 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study

Makoto Kajizono, Hikaru Sada, Yuhko Sugiura et al. · Biological and Pharmaceutical Bulletin · 2015 · 78 citations · Full text

Medicine, Oncology, Pharmacology +9

Co-induction of argininosuccinate synthetase, cationic amino acid transporter-2, and nitric oxide synthase in activated murine microglial cells

Kohichi Kawahara, Tomomi Gotoh, Seiichi Oyadomari et al. · Molecular Brain Research · 2001 · 65 citations

Life Sciences, Immunology, Neuroscience +13

Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw

Tomoko Higuchi, Yoshihiko Soga, Misato Muro et al. · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · 2018 · 43 citations · Full text

Medicine, Maxillofacial Surgery, Bone Metabolism +8

Refractory cachexia is associated with increased plasma concentrations of fentanyl in cancer patients

Manabu Suno, Yuriko Endo, Hiroyuki Nishie et al. · Therapeutics and Clinical Risk Management · 2015 · 15 citations · Full text

Medicine, Oncology, Pharmacology +11